Literature DB >> 25733685

Nfkb1 activation by the E26 transformation-specific transcription factors PU.1 and Spi-B promotes Toll-like receptor-mediated splenic B cell proliferation.

Stephen K H Li1, Ali K Abbas2, Lauren A Solomon2, Gaëlle M N Groux2, Rodney P DeKoter3.   

Abstract

Generation of antibodies against T-independent and T-dependent antigens requires Toll-like receptor (TLR) engagement on B cells for efficient responses. However, the regulation of TLR expression and responses in B cells is not well understood. PU.1 and Spi-B (encoded by Sfpi1 and Spib, respectively) are transcription factors of the E26 transformation-specific (ETS) family and are important for B cell development and function. It was found that B cells from mice knocked out for Spi-B and heterozygous for PU.1 (Sfpi1(+/-) Spib(-/-) [PUB] mice) proliferated poorly in response to TLR ligands compared to wild-type (WT) B cells. The NF-κB family member p50 (encoded by Nfkb1) is required for lipopolysaccharide (LPS) responsiveness in mice. PUB B cells expressed reduced Nfkb1 mRNA transcripts and p50 protein. The Nfkb1 promoter was regulated directly by PU.1 and Spi-B, as shown by reporter assays and chromatin immunoprecipitation analysis. Occupancy of the Nfkb1 promoter by PU.1 was reduced in PUB B cells compared to that in WT B cells. Finally, infection of PUB B cells with a retroviral vector encoding p50 substantially restored proliferation in response to LPS. We conclude that Nfkb1 transcriptional activation by PU.1 and Spi-B promotes TLR-mediated B cell proliferation.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25733685      PMCID: PMC4387210          DOI: 10.1128/MCB.00117-15

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  59 in total

1.  Comparative in vitro analysis of proliferation, Ig secretion, and Ig class switching by murine marginal zone and follicular B cells.

Authors:  C M Snapper; H Yamada; D Smoot; R Sneed; A Lees; J J Mond
Journal:  J Immunol       Date:  1993-04-01       Impact factor: 5.422

2.  Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages.

Authors:  E W Scott; M C Simon; J Anastasi; H Singh
Journal:  Science       Date:  1994-09-09       Impact factor: 47.728

3.  Spi-B can functionally replace PU.1 in myeloid but not lymphoid development.

Authors:  Richard Dahl; Diana L Ramirez-Bergeron; Sridhar Rao; M Celeste Simon
Journal:  EMBO J       Date:  2002-05-01       Impact factor: 11.598

4.  Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression.

Authors:  F Köntgen; R J Grumont; A Strasser; D Metcalf; R Li; D Tarlinton; S Gerondakis
Journal:  Genes Dev       Date:  1995-08-15       Impact factor: 11.361

5.  B cells from p50/NF-kappa B knockout mice have selective defects in proliferation, differentiation, germ-line CH transcription, and Ig class switching.

Authors:  C M Snapper; P Zelazowski; F R Rosas; M R Kehry; M Tian; D Baltimore; W C Sha
Journal:  J Immunol       Date:  1996-01-01       Impact factor: 5.422

6.  Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses.

Authors:  W C Sha; H C Liou; E I Tuomanen; D Baltimore
Journal:  Cell       Date:  1995-01-27       Impact factor: 41.582

7.  Analysis of the Bruton's tyrosine kinase gene promoter reveals critical PU.1 and SP1 sites.

Authors:  A Himmelmann; C Thevenin; K Harrison; J H Kehrl
Journal:  Blood       Date:  1996-02-01       Impact factor: 22.113

8.  Transcriptional regulation of the gene encoding the human C-type lectin leukocyte receptor AIM/CD69 and functional characterization of its tumor necrosis factor-alpha-responsive elements.

Authors:  M López-Cabrera; E Muñoz; M V Blázquez; M A Ursa; A G Santis; F Sánchez-Madrid
Journal:  J Biol Chem       Date:  1995-09-15       Impact factor: 5.157

9.  DNA binding specificities of Spi-1/PU.1 and Spi-B transcription factors and identification of a Spi-1/Spi-B binding site in the c-fes/c-fps promoter.

Authors:  D Ray-Gallet; C Mao; A Tavitian; F Moreau-Gachelin
Journal:  Oncogene       Date:  1995-07-20       Impact factor: 9.867

10.  The Ets protein Spi-B is expressed exclusively in B cells and T cells during development.

Authors:  G H Su; H S Ip; B S Cobb; M M Lu; H M Chen; M C Simon
Journal:  J Exp Med       Date:  1996-07-01       Impact factor: 14.307

View more
  7 in total

1.  PU.1 supports TRAIL-induced cell death by inhibiting NF-κB-mediated cell survival and inducing DR5 expression.

Authors:  Aladin Haimovici; Magali Humbert; Elena A Federzoni; Deborah Shan-Krauer; Thomas Brunner; Steffen Frese; Thomas Kaufmann; Bruce E Torbett; Mario P Tschan
Journal:  Cell Death Differ       Date:  2017-03-31       Impact factor: 15.828

Review 2.  Molecular control of activation and priming in macrophages.

Authors:  Christopher K Glass; Gioacchino Natoli
Journal:  Nat Immunol       Date:  2016-01       Impact factor: 25.606

3.  Coordination of Myeloid Differentiation with Reduced Cell Cycle Progression by PU.1 Induction of MicroRNAs Targeting Cell Cycle Regulators and Lipid Anabolism.

Authors:  Lauren A Solomon; Shreya Podder; Jessica He; Nicholas L Jackson-Chornenki; Kristen Gibson; Rachel G Ziliotto; Jess Rhee; Rodney P DeKoter
Journal:  Mol Cell Biol       Date:  2017-05-02       Impact factor: 4.272

4.  Driver mutations in Janus kinases in a mouse model of B-cell leukemia induced by deletion of PU.1 and Spi-B.

Authors:  Carolina R Batista; Michelle Lim; Anne-Sophie Laramée; Faisal Abu-Sardanah; Li S Xu; Rajon Hossain; Gillian I Bell; David A Hess; Rodney P DeKoter
Journal:  Blood Adv       Date:  2018-11-13

5.  Environmental sensing by mature B cells is controlled by the transcription factors PU.1 and SpiB.

Authors:  Simon N Willis; Julie Tellier; Yang Liao; Stephanie Trezise; Amanda Light; Kristy O'Donnell; Lee Ann Garrett-Sinha; Wei Shi; David M Tarlinton; Stephen L Nutt
Journal:  Nat Commun       Date:  2017-11-10       Impact factor: 14.919

6.  Therapeutic targeting of SPIB/SPI1-facilitated interplay of cancer cells and neutrophils inhibits aerobic glycolysis and cancer progression.

Authors:  Jianqun Wang; Xiaojing Wang; Yanhua Guo; Lin Ye; Dan Li; Anpei Hu; Shuang Cai; Boling Yuan; Shikai Jin; Yi Zhou; Qilan Li; Liduan Zheng; Qiangsong Tong
Journal:  Clin Transl Med       Date:  2021-11

7.  Comprehensive pan-cancer analysis reveals the prognostic value and immunological role of SPIB.

Authors:  Meng Ding; Qiufang Li; Xiao Tan; Liangyua Zhang; Jun Tan; Lan Zheng
Journal:  Aging (Albany NY)       Date:  2022-08-14       Impact factor: 5.955

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.